Sana Biotechnology, Inc. SANA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-02-04
Sana Biotechnology, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 11,045,448 | $60.3M |
| MILLENNIUM MANAGEMENT LLC | 1,591,030 | $4.6M |
| RENAISSANCE TECHNOLOGIES LLC | 1,451,200 | $4.2M |
| TWO SIGMA INVESTMENTS, LP | 1,198,579 | $3.5M |
| AQR CAPITAL MANAGEMENT LLC | 1,124,279 | $3.2M |
| CITADEL ADVISORS LLC | 769,790 | $2.2M |
| D. E. Shaw & Co., Inc. | 38,670 | $111,369 |
Source: SEC EDGAR filings · CIK 0001770121 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.